Blume Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Blume Capital Management, Inc. holds 23 biotech & pharma companies tracked by BioSniper, totaling $26.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$26.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 52,694 | $12.9M |
| PFEPFIZER INC | 238,095 | $6.7M |
| ELVElevance Health Inc. | 11,026 | $3.2M |
| SNYSanofi | 48,531 | $2.3M |
| GILDGILEAD SCIENCES, INC. | 3,195 | $445K |
| AMGNAMGEN INC | 530 | $186K |
| MRKMerck & Co., Inc. | 1,400 | $168K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 290 | $78K |
| ABTABBOTT LABORATORIES | 750 | $77K |
| BMYBRISTOL MYERS SQUIBB CO | 1,054 | $64K |
| GEHCGE HealthCare Technologies Inc. | 840 | $60K |
| LLYELI LILLY & Co | 60 | $55K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 800 | $44K |
| PMPhilip Morris International Inc | 250 | $41K |
| CAHCardinal Health Inc. | 100 | $21K |
| NVONovo Nordisk A/S | 437 | $16K |
| BAXBaxter International Inc. | 700 | $12K |
| ABCLAbCellera Biologics Inc. | 2,800 | $10K |
| GMOptec International, Inc. | 103 | $8K |
| MRNAModerna, Inc. | 45 | $2K |
| INOINOVIO PHARMACEUTICALS, INC. | 83 | $145 |
| VTRSViatris Inc | 3 | $41 |
| OGNOrganon & Co. | 5 | $30 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.